Bristol Myers Squibb has announced plans to construct a $2.3 billion manufacturing campus in Houston, marking one of the pharmaceutical giant’s largest domestic investments as it expands its production footprint in the United States.
The new facility will strengthen the company’s manufacturing capabilities and add high-skilled jobs to the Texas economy, reinforcing a broader trend of major drugmakers channeling billions into American production sites.
The investment comes amid mounting pressure on pharmaceutical companies to onshore manufacturing operations, driven by supply-chain resilience concerns and shifting trade policy. Several industry peers have unveiled comparable commitments in recent months, including Eli Lilly’s multibillion-dollar cancer drug plant planned for Virginia.
Bristol Myers Squibb, one of the world’s largest biopharmaceutical firms, produces treatments spanning oncology, cardiovascular disease, immunology and neuroscience. The Houston campus is expected to support the manufacture of products across its portfolio and expand capacity for future therapies.
Texas has increasingly courted life-sciences investment, offering a growing talent pool and business incentives that have drawn manufacturers to the region. The Houston project is anticipated to generate significant construction activity and permanent employment once operational.
The announcement follows a wave of similar expansions across the sector, including Amgen’s investment to grow its Ohio manufacturing operations, as drugmakers race to secure domestic capacity.
Bristol Myers Squibb has continued to invest in its pipeline and infrastructure as it navigates patent expirations on several key medicines and works to bring newer treatments to market. The company has reported steady revenue in recent quarters while expanding its research and production base.
Construction timelines and the number of jobs to be created have not been fully detailed, though the scale of the investment signals a long-term commitment to U.S. manufacturing. The project is expected to come online in the coming years as part of the company’s broader capacity expansion strategy.